The Effects Of Music In Retrograde Intrarenal Surgery

Sponsor
Afyonkarahisar Health Sciences University (Other)
Overall Status
Completed
CT.gov ID
NCT04500054
Collaborator
(none)
60
1
2
7.6
7.9

Study Details

Study Description

Brief Summary

This study aimed to investigate the effect of music listening during the preoperative and postoperative stages in patients undergoing retrograde intrarenal surgery(RIRS) on basic life findings, anxiety, pain, and the amount of analgesic used. This is a randomized controlled experimental study.

The study was conducted with two groups: the intervention group (n=30) and control group (n=30). The control group received standard care. In contrast, the intervention group, in addition to standard care, was listened to the music by the researchers for 15 minutes one hour before their surgery.

Condition or Disease Intervention/Treatment Phase
  • Other: Music Listening
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
The Effects Of Music Listening In Patients Undergoing Retrograde Intrarenal Surgery On Basic Life Findings, Anxiety, Pain, And The Amount Of Analgesic Used.
Actual Study Start Date :
May 14, 2019
Actual Primary Completion Date :
Dec 31, 2019
Actual Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Music Intervention Group

The music intervention group listened to the music by the researchers for the duration of 15 minutes one hour before the surgery as well as the standard care.

Other: Music Listening
The music type was chosen by the patients and researchers did not have any influence on their choices.

No Intervention: No Intervention Group

The control group patients received standard care only.

Outcome Measures

Primary Outcome Measures

  1. Visual Analog Scale for Anxiety (VAS-A) [2 days]

    VAS-A is a 10 cm long measuring instrument with the score range from 0 to 10 with 0 points showing "no anxiety" and 10 points showing "I feel a lot of anxiety" .

Secondary Outcome Measures

  1. Visual Analog Scale for Pain (VAS) [1 day]

    VAS scale is a single-dimensional scale that is commonly used to evaluate pain severity. According to VAS, pain intensity is rated as "no pain" with 0 points, and "the most severe pain imaginable" with 10 points. Pain intensity ranges were determined by VAS as follows; mild pain below 3 points, as moderate pain between 3 and 6 points, and as severe pain above 6 points.The VAS pain scale was applied to the patients once on the first postoperative day, for the level of pain they felt.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18 years of age or above,

  • had elective RIRS,

  • without hearing/speech impairment,

  • without mental problems,

  • without a diagnosis of psychiatric disorders,

  • without a diagnosis of depression,

  • had the surgery under general anesthesia,

  • and volunteered to participate.

Exclusion Criteria:
  • Patients under 18 years of age,

  • with hearing/speech impairment,

  • with mental problems,

  • with a diagnosis of psychiatric disorders,

  • with a diagnosis of depression,

  • undergoing the surgery through spinal anesthesia,

  • not willing to participate in the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Afyonkarahisar Health Science University Afyonkarahisar Centre Turkey 03200

Sponsors and Collaborators

  • Afyonkarahisar Health Sciences University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yeliz Ciğerci, Assistant Proffesor PhD, Afyonkarahisar Health Sciences University
ClinicalTrials.gov Identifier:
NCT04500054
Other Study ID Numbers:
  • (2019/165
First Posted:
Aug 5, 2020
Last Update Posted:
Aug 5, 2020
Last Verified:
Aug 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Aug 5, 2020